EUVIMEDEUVIMED entdecken
Crossref

The deubiquitinating enzyme USP 8 promotes tyrosine kinase inhibitors resistance in chronic myeloid leukemia by stabilizing EIF 2 S 1 protein

Shan Zhang, Hurong Lai, Wanwan Bao, Caifeng Liao, Jian Li iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Shan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Hematology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Drug Resistance, Neoplasm, Ubiquitin Thiolesterase, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Jiangxi Province Key Research and Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine kinase inhibitors (TKIs), targeted therapeutic agents, have significantly improved survival outcomes in patients with chronic myeloid leukemia (CML). However, the emergence of drug resistance remains a challenge, with the underlying mechanisms still largely unknown. Deubiquitinating enzymes (DUBs) have been reported as potential targets in many human cancers. In this study, we identified ubiquitin‐specific protease 8 (USP8) as a potential prognostic target for CML drug resistance through bioinformatics analysis and validation in clinical samples. Functionally, knockdown of USP8 inhibited proliferation and increased apoptosis and TKI sensitivity in various CML cell lines. Mechanistically, immunoprecipitation‐mass spectrometry analysis and molecular docking demonstrated an interaction between USP8 and eukaryotic translation initiation factor 2 subunit alpha (EIF2S1). USP8 stabilizes EIF2S1 protein by inhibiting its K48‐linked ubiquitination, thereby preventing its degradation via the proteasome pathway. In other words, USP8 knockdown suppressed EIF2S1 protein expression and inhibited tumor growth both in vitro and in vivo , further suppressing TKI resistance. In summary, our results suggest that USP8 is overexpressed in CML and linked to resistance to TKIs. We have unveiled a previously unknown mechanism of CML drug resistance, which may provide novel perspectives on the advancement of targeted therapeutic strategies and clinical interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Resistance, NeoplasmUbiquitin ThiolesteraseProtein Kinase InhibitorsEukaryotic Initiation Factor-2EndopeptidasesHumansAnimalsMiceUbiquitinationCell Line, TumorCell ProliferationApoptosisMolecular Docking SimulationFemaleMice, NudeXenograft Model Antitumor AssaysK562 CellsMaleTyrosine Kinase InhibitorsEndosomal Sorting Complexes Required for Transport

Stichwörter der Autor:innen

CMLEIF2S1TKIs resistanceUSP8targeted therapy

Substanzen

Ubiquitin ThiolesteraseProtein Kinase InhibitorsEukaryotic Initiation Factor-2EIF2S1 protein, humanUSP8 protein, humanEndopeptidasesTyrosine Kinase InhibitorsEndosomal Sorting Complexes Required for Transport

Autor:innen und Institutionen

  • The Department of Hematology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.

ORCID-Profile: Jian Li

Förderung

  • Jiangxi Province Key Research and Development Program
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, S., Lai, H., Bao, W., Liao, C., & Li, J. (2025). The deubiquitinating enzyme USP 8 promotes tyrosine kinase inhibitors resistance in chronic myeloid leukemia by stabilizing EIF 2 S 1 protein. The FEBS Journal. https://doi.org/10.1111/febs.70300

Vancouver

Zhang S, Lai H, Bao W, Liao C, Li J. The deubiquitinating enzyme USP 8 promotes tyrosine kinase inhibitors resistance in chronic myeloid leukemia by stabilizing EIF 2 S 1 protein. The FEBS Journal. 2025. doi:10.1111/febs.70300

BibTeX
@article{Zhang2025,
  author = {Zhang, Shan and Lai, Hurong and Bao, Wanwan and Liao, Caifeng and Li, Jian},
  title = {The deubiquitinating enzyme USP 8 promotes tyrosine kinase inhibitors resistance in chronic myeloid leukemia by stabilizing EIF 2 S 1 protein},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70300}
}
Kostenlos starten →